XML 110 R95.htm IDEA: XBRL DOCUMENT v3.25.0.1
Variable Interest Entities - Schedule of Operating Results (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Variable Interest Entity [Line Items]      
Revenues $ 6,060,530 $ 4,316,363 $ 2,388,220
Income (loss) from operations (292,130) (232,133) (105,378)
Net income (loss) (260,151) (262,596) (106,553)
Other income (expense), net 34,489 27,840 13,930
Equity Method Investment, Nonconsolidated Investee or Group of Investees      
Variable Interest Entity [Line Items]      
Income (loss) from operations 22,687 22,500 14,294
Net income (loss) 15,050 16,336 10,556
Physician compensation expense 58,400 53,700 27,100
Physician compensation expense, exchange for common stock   15,200  
Equity Method Investment, Nonconsolidated Investee or Group of Investees | CMS ACO Models      
Variable Interest Entity [Line Items]      
Revenues 3,900 1,600 1,600
Other income (expense), net 14,900 2,900 2,800
Medical services revenue      
Variable Interest Entity [Line Items]      
Revenues 6,047,715 4,307,350 2,384,889
Expenses (5,842,530) (4,008,659) (2,093,860)
Medical services revenue | Equity Method Investment, Nonconsolidated Investee or Group of Investees      
Variable Interest Entity [Line Items]      
Revenues 1,814,618 1,160,978 1,071,302
Expenses (1,667,806) (1,024,468) (991,565)
Other operating revenue      
Variable Interest Entity [Line Items]      
Revenues 12,815 9,013 3,331
Expenses (213,159) (238,034) (183,000)
Other operating revenue | Equity Method Investment, Nonconsolidated Investee or Group of Investees      
Variable Interest Entity [Line Items]      
Expenses $ (89,788) $ (96,154) $ (52,041)